Evid Based Med doi:10.1136/eb-2012-101138
  • Prevention
  • Systematic review

Vaccination of older adults against herpes zoster is safe and effective

  1. Stephen K Tyring
  1. Department of Dermatology, University of Texas, Houston, Texas, USA
  1. Correspondence to : Dr Stephen K Tyring
    Department of Dermatology, University of Texas, 451 North Texas Ave, Houston, TX 77598, USA; styring{at}

Commentary on:


The problem addressed by this study is that older individuals, for example, those over 60 years of age, are more likely to develop herpes zoster (HZ) than younger people. Older adults are far more likely to develop severe complications of HZ, especially postherpetic neuralgia (PHN).


Gagliardi and colleagues reviewed eight randomised controlled trials (RCTs) involving 52 269 participants.


By focusing on RCTs and assessing the risk of bias in these studies, the authors concluded that vaccination against HZ is safe and effective. The risk of HZ was less compared to placebo: risk ratio (RR) 0.49 (95% CI 0.43 to 0.56), with a …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBM.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article